Authors: Takahashi, S Takagi, K Horikomi, K

Citation: S. Takahashi et al., Effects of a novel, selective, sigma(1)-ligand, MS-377, on phencyclidine-induced behaviour, N-S ARCH PH, 364(1), 2001, pp. 81-86

Authors: Takahashi, S Horikomi, K Kato, T

Citation: S. Takahashi et al., MS-377, a novel selective sigma(1) receptor ligand, reverses phencyclidine-induced release of dopamine and serotonin in rat brain, EUR J PHARM, 427(3), 2001, pp. 211-219

Authors: Yamamoto, H Karasawa, J Sagi, N Takahashi, S Horikomi, K Okuyama, S Nukada, T Sora, I Yamamoto, T

Citation: H. Yamamoto et al., Multiple pathways of sigma(1) receptor ligand uptakes into primary cultured neuronal cells, EUR J PHARM, 425(1), 2001, pp. 1-9

Authors: Takahashi, S Miwa, T Horikomi, K

Citation: S. Takahashi et al., Involvement of sigma(1) receptors in methamphetamine-induced behavioral sensitization in rats, NEUROSCI L, 289(1), 2000, pp. 21-24

Authors: Karasawa, J Takahashi, S Horikomi, K

Citation: J. Karasawa et al., Binding properties of [H-3]MS-377, a novel sigma receptor ligand, to rat brain membranes, EUR J PHARM, 400(1), 2000, pp. 51-57

Authors: Takahashi, S Sonehara, K Takagi, K Miwa, T Horikomi, K Mita, N Nagase, H Iizuka, K Sakai, K

Citation: S. Takahashi et al., Pharmacological profile of MS-377, a novel antipsychotic agent with selective affinity for sigma receptors, PSYCHOPHAR, 145(3), 1999, pp. 295-302